• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY ORTHOPAEDICS INC US BI MENTUM PFRK PE LINER 22 43; BI MENTUM LINER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY ORTHOPAEDICS INC US BI MENTUM PFRK PE LINER 22 43; BI MENTUM LINER Back to Search Results
Model Number BI-MENTUM PE Liner 22,2 / 43
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Unspecified Infection (1930)
Date of Event 11/29/2022
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that patient had i&d of hip.Liner and head exchanged.Infection was confirmed.Doi: (b)(6) 2022.Dor: (b)(6) 2022.Affected side: left hip.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).Although distributed by depuy synthes joint reconstruction, the product is designed, manufactured, and labeled by the manufacturing supplier.The requirement of fda reporting, complaint investigation, root cause, and corrective action is the responsibility of the designing supplier of this item, per the supplier agreement.The product/information will be transferred to the supplier with the complaint problem statement for investigation.The results of the supplier investigation are to be populated into the depuy synthes customer quality complaint management system.Per the supplier agreement, the supplier is responsible for any corrective actions identified during the complaint investigation process.The products were not returned, no product for investigation can be performed.No x ray has been provided, no information.All batches are released in compliance with specifications the supplier has no evidence to determine the cause of the complaint.Revision leading to implant replacement can be caused by several factors that cannot be demonstrated due to lack of information.The supplier devices involvement is unlikely in these cases.The root causes of these events remain undetermined.No further investigation with regard to this complaint is required.The supplier will continue to monitor for trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BI MENTUM PFRK PE LINER 22 43
Common Device Name
BI MENTUM LINER
Manufacturer (Section D)
DEPUY ORTHOPAEDICS INC US
700 orthopaedic drive
warsaw IN 46581 0988
MDR Report Key15979193
Report Number1818910-2022-50049
Device Sequence Number17873219
Product Code LPH
UDI-Device Identifier03662200015504
UDI-Public03662200015504
Combination Product (Y/N)N
Initial Reporter StateOR
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2022
Device Explanted Year2022
Serviced by Third Party (Y/N)Unknown
Reporter Type Importer
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 12/14/2022
Report Date (Section F) 12/14/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberBI-MENTUM PE Liner 22,2 / 43
Device Catalogue NumberDS10014322
Device Lot Number2006241A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Distributor Facility Aware Date11/29/2022
Event Location Hospital
Date Report to Manufacturer12/02/2022
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date12/14/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured02/05/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ARTICUL/EZE BALL 22.225+4 NK.; BI MENTUM PFRK PE LINER 22 43.
Outcome Attributed to Adverse Event Required Intervention;
Patient SexFemale
Date Report Sent to FDA12/14/2022
-
-